Us Congress 2025-2026 Regular Session

Us Congress House Bill HR394 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	IV
2	2	119THCONGRESS
3	3	1
4	4	STSESSION H. RES. 394
5	5	Expressing support for the designation of July 16, 2025, as ‘‘Glioblastoma
6	6	Awareness Day’’.
7	7	IN THE HOUSE OF REPRESENTATIVES
8	8	MAY6, 2025
9	9	Mr. W
10	10	ILLIAMSof Texas (for himself, Mr. MAST, Ms. SCHAKOWSKY, and Mr.
11	11	A
12	12	UCHINCLOSS) submitted the following resolution; which was referred to
13	13	the Committee on Energy and Commerce
14	14	RESOLUTION
15	15	Expressing support for the designation of July 16, 2025,
16	16	as ‘‘Glioblastoma Awareness Day’’.
17	17	Whereas it is estimated that more than 13,000 Americans
18	18	will be diagnosed with glioblastoma in 2025;
19	19	Whereas glioblastoma is—
20	20	(1) the most common malignant (cancerous) brain
21	21	tumor, accounting for approximately
22	22	1
23	23	⁄2of all primary
24	24	malignant brain tumors; and
25	25	(2) the most aggressive, complex, difficult to treat,
26	26	and deadly type of brain tumor;
27	27	Whereas it is estimated that more than 10,000 individuals in
28	28	the United States will succumb to glioblastoma each year;
29	29	VerDate Sep 11 2014 22:19 May 06, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR394.IH HR394
30	30	ssavage on LAPJG3WLY3PROD with BILLS 2
31	31	•HRES 394 IH
32	32	Whereas the 5-year survival rate for glioblastoma patients is
33	33	only 6.9 percent, and the median length of survival for
34	34	glioblastoma patients is only 8 months;
35	35	Whereas glioblastoma is described as a disease that affects
36	36	the ‘‘essence of self’’, as the treatment and removal of
37	37	glioblastoma presents significant challenges due to the
38	38	uniquely complex and fragile nature of the brain, the pri-
39	39	mary organ in the human body that controls not only
40	40	cognitive ability, but also the actions of every organ and
41	41	limb;
42	42	Whereas patients and caregivers play a critical role in fur-
43	43	thering research for glioblastoma;
44	44	Whereas, relative to other types of cancers, brain cancer pa-
45	45	tients pay the second highest out-of-pocket costs for med-
46	46	ical services in both the initial and end-of-life phases of
47	47	care;
48	48	Whereas, although research advances may fuel the develop-
49	49	ment of new treatments for glioblastoma, challenging ob-
50	50	stacles to accelerating progress toward new treatments
51	51	for glioblastoma remain, and there are no screening or
52	52	early detection methods;
53	53	Whereas, in 2021, significant changes were made to the mo-
54	54	lecular characteristics of a glioblastoma diagnosis, neces-
55	55	sitating critical biomarker testing for patients suspected
56	56	of having a possible glioblastoma;
57	57	Whereas, although glioblastoma was first described in medical
58	58	and scientific literature in the 1920s, and despite its dev-
59	59	astating prognosis, only 5 drugs and 1 medical device
60	60	have been approved by the Food and Drug Administra-
61	61	tion to specifically treat glioblastoma since the 1920s,
62	62	VerDate Sep 11 2014 22:19 May 06, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6300 E:\BILLS\HR394.IH HR394
63	63	ssavage on LAPJG3WLY3PROD with BILLS 3
64	64	•HRES 394 IH
65	65	and the mortality rates associated with glioblastoma have
66	66	changed little during the past 30 years;
67	67	Whereas, since the first Glioblastoma Awareness Day, the
68	68	National Cancer Institute established the Glioblastoma
69	69	Therapeutics Network (referred to in this preamble as
70	70	‘‘GTN’’) in 2020 as part of a national infrastructure to
71	71	enhance and support the discovery and development of
72	72	glioblastoma therapies available for multi-institutional
73	73	GTN teams to drive therapeutic agents through pre-
74	74	clinical studies and early phase clinical trials, which are
75	75	necessary to rapidly evaluate potential treatments to ad-
76	76	vance toward cures and improved quality of life;
77	77	Whereas there is a need for greater public awareness of glio-
78	78	blastoma, including awareness of both—
79	79	(1) the urgent unmet medical needs of glioblastoma
80	80	patients; and
81	81	(2) the opportunities for research of, and treatment
82	82	advances for, glioblastoma; and
83	83	Whereas the House of Representatives supports designating
84	84	July 16, 2025, as ‘‘Glioblastoma Awareness Day’’: Now,
85	85	therefore, be it
86	86	Resolved, That the House of Representatives— 1
87	87	(1) expresses support for the designation of 2
88	88	‘‘Glioblastoma Awareness Day’’; 3
89	89	(2) encourages increased public awareness of 4
90	90	glioblastoma; 5
91	91	(3) honors the individuals who have died from 6
92	92	the devastating disease of glioblastoma or are cur-7
93	93	rently living with the disease; 8
94	94	VerDate Sep 11 2014 22:19 May 06, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\HR394.IH HR394
95	95	ssavage on LAPJG3WLY3PROD with BILLS 4
96	96	•HRES 394 IH
97	97	(4) supports efforts to develop better treat-1
98	98	ments for glioblastoma that will improve the long- 2
99	99	term prognosis for, and the quality of life of, individ-3
100	100	uals diagnosed with the disease; 4
101	101	(5) recognizes the importance of molecular bio-5
102	102	marker testing to the diagnosis and treatment of 6
103	103	glioblastoma; 7
104	104	(6) expresses support for the individuals who 8
105	105	are battling brain tumors, as well as the families, 9
106	106	friends, and caregivers of those individuals; 10
107	107	(7) urges a collaborative approach to brain 11
108	108	tumor research among governmental, private, and 12
109	109	nonprofit organizations, which is a promising means 13
110	110	of advancing the understanding and treatment of 14
111	111	glioblastoma; and 15
112	112	(8) encourages continued investments in glio-16
113	113	blastoma research and treatments, including through 17
114	114	the Glioblastoma Therapeutics Network and other 18
115	115	existing brain tumor research resources. 19
116	116	Æ
117	117	VerDate Sep 11 2014 22:19 May 06, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6301 E:\BILLS\HR394.IH HR394
118	118	ssavage on LAPJG3WLY3PROD with BILLS